The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 29, 2023
Filed:
Sep. 23, 2020
Applicant:
Syneurx International (Taiwan) Corp., New Taipei, TW;
Inventors:
Guochuan Emil Tsai, Pasadena, CA (US);
Ching-Cheng Wang, New Taipei, TW;
Tien-Lan Hsieh, New Taipei, TW;
Yuan-Chun Lo, New Taipei, TW;
Assignee:
SyneuRx International (Taiwan) Corp., New Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/80 (2006.01); C07C 63/08 (2006.01); A61K 33/14 (2006.01); A61P 35/00 (2006.01); C07C 215/54 (2006.01); A61P 25/28 (2006.01); A61P 25/22 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); C07C 57/10 (2006.01);
U.S. Cl.
CPC ...
C07C 63/08 (2013.01); A61K 33/14 (2013.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01); C07C 57/10 (2013.01); C07C 215/54 (2013.01); C07D 213/80 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present disclosure provides co-crystals of a lithium benzoate compound and a co-former compound of Formula (I) Also provided herein are methods of preparing the co-crystals and uses thereof in treating and/or reducing the risk for neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, bipolar disorders, or neurogenerative disorders).